Overview

VPIA Remifentanil for Labour Pain to Reduce Maternal Desaturation and Improve Analgesic Titration

Status:
Unknown status
Trial end date:
2018-03-01
Target enrollment:
Participant gender:
Summary
This study is a prospective cohort study aiming to evaluate an improved VPIA remifentanil algorithm which would benefit labouring mothers who are unable or unwilling to receive epidural analgesia
Phase:
Phase 4
Details
Lead Sponsor:
KK Women's and Children's Hospital
Treatments:
Analgesics
Remifentanil